Amalgamated Bank’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $511K | Sell |
35,007
-2,230
| -6% | -$21.5K | ﹤0.01% | 1355 |
|
|
2026
Q1 | $276K | Sell |
37,237
-290
| -0.8% | -$3.05K | ﹤0.01% | 1488 |
|
|
2025
Q4 | $441K | Sell |
37,527
-438
| -1% | -$4.72K | ﹤0.01% | 1363 |
|
|
2025
Q3 | $293K | Buy |
37,965
+1,255
| +3% | +$8.79K | ﹤0.01% | 1467 |
|
|
2025
Q2 | $268K | Hold |
36,710
| – | – | ﹤0.01% | 1477 |
|
|
2025
Q1 | $348K | Sell |
36,710
-1,266
| -3% | -$15.8K | ﹤0.01% | 1380 |
|
|
2024
Q4 | $626K | Sell |
37,976
-30
| -0.1% | -$466 | 0.01% | 1228 |
|
|
2024
Q3 | $561K | Sell |
38,006
-1,004
| -3% | -$15.7K | ﹤0.01% | 1259 |
|
|
2024
Q2 | $541K | Sell |
39,010
-1,513
| -4% | -$21.4K | ﹤0.01% | 1274 |
|
|
2024
Q1 | $637K | Sell |
40,523
-7,820
| -16% | -$121K | 0.01% | 1219 |
|
|
2023
Q4 | $782K | Sell |
48,343
-1,777
| -4% | -$29.1K | 0.01% | 1257 |
|
|
2023
Q3 | $616K | Sell |
50,120
-1,656
| -3% | -$24.6K | 0.01% | 1317 |
|
|
2023
Q2 | $832K | Sell |
51,776
-1,270
| -2% | -$20.9K | 0.01% | 1198 |
|
|
2023
Q1 | $924K | Sell |
53,046
-4,277
| -7% | -$60.9K | 0.01% | 1148 |
|
|
2022
Q4 | $530K | Buy |
57,323
+406
| +0.7% | +$3.79K | ﹤0.01% | 1439 |
|
|
2022
Q3 | $490K | Buy |
56,917
+861
| +2% | +$8.55K | ﹤0.01% | 1442 |
|
|
2022
Q2 | $457K | Sell |
56,056
-3,298
| -6% | -$31.5K | ﹤0.01% | 1505 |
|
|
2022
Q1 | $721K | Sell |
59,354
-2,304
| -4% | -$48.5K | 0.01% | 1378 |
|
|
2021
Q4 | $2.1M | Sell |
61,658
-1,261
| -2% | -$49.4K | 0.02% | 917 |
|
|
2021
Q3 | $3.04M | Sell |
62,919
-118
| -0.2% | -$5.46K | 0.03% | 752 |
|
|
2021
Q2 | $2.85M | Buy |
63,037
+46,559
| +283% | +$2.06M | 0.02% | 802 |
|
|
2021
Q1 | $795K | Sell |
16,478
-870
| -5% | -$45.3K | 0.03% | 710 |
|
|
2020
Q4 | $934K | Buy |
17,348
+356
| +2% | +$16.1K | 0.04% | 583 |
|
|
2020
Q3 | $627K | Sell |
16,992
-558
| -3% | -$20.7K | 0.03% | 717 |
|
|
2020
Q2 | $544K | Sell |
17,550
-638
| -4% | -$17.7K | 0.03% | 786 |
|
|
2020
Q1 | $502K | Sell |
18,188
-829
| -4% | -$24.8K | 0.01% | 908 |
|
|
2019
Q4 | $556K | Buy |
19,017
+2,715
| +17% | +$64.7K | 0.01% | 1061 |
|
|
2019
Q3 | $312K | Sell |
16,302
-257
| -2% | -$6.03K | 0.01% | 1304 |
|
|
2019
Q2 | $363K | Buy |
16,559
+3,853
| +30% | +$84.5K | 0.01% | 1240 |
|
|
2019
Q1 | $260K | Buy |
+12,706
| New | +$221K | 0.01% | 1351 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Amalgamated Bank's NEO Position: Q2 2026 in Review
Amalgamated Bank reduced its NeoGenomics (NEO) stake by 6% in Q2 2026, selling an estimated $21.5K and leaving 35,007 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.
Amalgamated Bank first reported a position in NEO in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.04M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Amalgamated Bank held 35,007 shares of NeoGenomics worth $511K as of Q2 2026.
- Amalgamated Bank sold 2,230 NeoGenomics shares in Q2 2026, an estimated $21.5K.
- NeoGenomics made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1355 holding.
- Amalgamated Bank first reported a position in NeoGenomics in Q1 2019 and has held it in 30 quarters since.
- Amalgamated Bank's NeoGenomics position peaked at $3.04M in Q3 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.